Descripción de negocio
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Consejo de gestión & Consejo de supervisión
| CEO |
| Daniel O’Day |
| Consejo de gestión |
| Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Johanna Mercier, Cindy Perettie, Deborah H. Telman |
| Consejo de supervisión |
| Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Kevin E. Lofton, Harish Manwani, Harish Manwani, Anthony Welters |
Datos de la empresa
| Nombre: |
Gilead Sciences Inc. |
| Dirección: |
333 Lakeside Drive,Foster City, California 94404, USA |
| Teléfono: |
+1-650-574-3000 |
| Fax: |
+1-650-578-9264 |
| E-mail: |
corporate_communicat...ead.com
corporate_communications@gilead.com
|
| Internet: |
www.gilead.com |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
55.84% |
| Fecha de OPI: |
22/01/1992 |
